Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julie L, Barben"'
Autor:
Jon E. Stek, Rudy Ifle, Florian P Schödel, Mark Tomlinson, Katia Schlienger, Julie L Barben, Kimberly Rarrick, Mi-Ok Chung, Alexander V Murray, William W B Wang, Boris Kerzner, Jin Xu, Eric Cheng, Jeffrey L Silber, Peter R Harvey, Ivan S F Chan
Publikováno v:
Journal of the American Geriatrics Society. 55:1499-1507
OBJECTIVES: To evaluate the safety and immunogenicity of ZOSTAVAX administered concomitantly with inactivated influenza vaccine or sequentially in adults aged 50 and older. DESIGN: Randomized, blinded, placebo-controlled study. SETTING: Thirteen U.S.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f52fca5a4c44162a978ab921b0e5ee1d
https://doi.org/10.1111/j.1532-5415.2007.01397.x
https://doi.org/10.1111/j.1532-5415.2007.01397.x
Autor:
Boris, Kerzner, Alexander V, Murray, Eric, Cheng, Rudy, Ifle, Peter R, Harvey, Mark, Tomlinson, Julie L, Barben, Kimberly, Rarrick, Jon E, Stek, Mi-Ok, Chung, Florian P, Schödel, William W B, Wang, Jin, Xu, Ivan S F, Chan, Jeffrey L, Silber, Katia, Schlienger
Publikováno v:
Journal of the American Geriatrics Society. 55(10)
To evaluate the safety and immunogenicity of ZOSTAVAX administered concomitantly with inactivated influenza vaccine or sequentially in adults aged 50 and older.Randomized, blinded, placebo-controlled study.Thirteen U.S. and seven European study sites
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::678b7c781c2dc70e6ad98825d1d8f954
https://pubmed.ncbi.nlm.nih.gov/17908055
https://pubmed.ncbi.nlm.nih.gov/17908055
Autor:
Rocio Gonzalez, Pietro Dentico, Katia Schlienger, Jon E. Stek, Andrew S. Robertson, Christina Y. Chan, Jeffrey G. Smith, Ira Chalikonda, Rupert Vessey, Clemente Diaz, Jeffrey L. Silber, William Wang, Florian Schödel, Holly Matthews, Jerald C. Sadoff, Rafael G Mendez, Michael J. Caulfield, Luigi Roberto Biasio, Ivan S. F. Chan, Julie L Barben, Anna L. Harmon, Sandro Cinquetti
Publikováno v:
Vaccine. 24(47-48)
A new manufacturing process, known as process upgrade varicella vaccine (PUVV) was developed for a refrigerated formulation of varicella vaccine and for an investigational zoster vaccine. Safety and tolerability of a two-dose regimen of high-titered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e2adba95e733738ebbad3811751ec51
https://pubmed.ncbi.nlm.nih.gov/17050042
https://pubmed.ncbi.nlm.nih.gov/17050042